- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04000308
QLB vs. Wound Infiltration in Cesarean Section
Quadratus Lumborum Block Type 2 Versus Wound Infiltration in Cesarean Section: a Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Effective postoperative analgesia after cesarean section (CS) is important because it enables early ambulation and facilitates breast-feeding. Post-CS analgesia is usually multimodal. At our hospital, patients are routinely given a combination of parenteral paracetamol, metamizole and tramadol at fixed intervals with additional intravenous piritramide on demand. The well-known side effects of piritramide (nausea, vomiting, and sedation) may interfere with interaction between mother and child, breast-feeding and post-partum experience in a dose-dependent manner. Alternative strategies to reduce rescue opioid analgesic consumption post-CS section are, therefore, required.
A 2009 Cochrane review concluded that wound infiltration with local analgesic after CS reduced opioid consumption. In addition, two regional anesthetic techniques, the transversus abdominis plane (TAP) block and the quadratus lumborum block (QLB), have been shown in multiple studies to reduce post-operative opioid consumption after CS. A recent randomized controlled trial showed that QLB is more effective in reducing morphine consumption post-CS compared to TAP.
Telnes et al. compared TAP block with wound infiltration with local anesthetic following CS. They found no reduction in cumulative morphine consumption and more pronounced sedation associated with TAP block. No randomized controlled trial to date, however, compared the analgesic effect of QLB with infiltration of the wound after CS.
The objective of the study is to compare the analgesic effect of QLB type 2 with wound infiltration after CS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- UMC Ljubljana
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parturients scheduled for an elective caesarean delivery under spinal anaesthesia with an American Society of Anesthesiologists physical status I or II, singleton pregnancy, and gestational age ≥ 37 completed weeks.
Exclusion Criteria:
- Congenital or acquired coagulopathy.
- Allergy to local anaesthetics.
- History of drug abuse.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Quadratus Lumborum Block type 2
The obstetrician (multiple, experienced clinicians) will infiltrate the wound (Pfannenstiel incision) subcutaneously at the end of surgery with 20 ml normal saline.
Subsequently, a US-guided QLB using a linear/convex transducer will be performed by the anesthesiologist using 30 ml levobupivacaine 0.18% (20 ml 0.25% levobupivacaine + 10 ml normal saline) bilaterally (60 ml in total).
|
The obstetrician (multiple, experienced clinicians) will infiltrate the wound (Pfannenstiel incision) subcutaneously at the end of surgery with 20 ml normal saline.
Subsequently, a US-guided QLB using a linear/convex transducer will be performed by the anesthesiologist using 30 ml levobupivacaine 0.18% (20 ml 0.25% levobupivacaine + 10 ml normal saline) bilaterally (60 ml in total).
|
Active Comparator: Wound Infiltration
Patricipants will receive 20 ml levobupivacaine 0.25% infiltration in the surgical wound and US-guided QLB with 30 ml normal saline bilaterally (60 ml in total).
|
Participants will receive 20 ml levobupivacaine 0.25% infiltration in the surgical wound and US-guided QLB with 30 ml normal saline bilaterally (60 ml in total).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total amount of piritramide used in first 24 hours
Time Frame: 24 hours post CS
|
Total amount of piritramide administered in the first 24 hours after CS
|
24 hours post CS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total amount of piritramide used in first 48 hours
Time Frame: 48 hours post CS
|
Total amount of piritramide administered in the first 48 hours after CS
|
48 hours post CS
|
Numerical rating scale (0-10) at rest
Time Frame: Within 48 hours post CS
|
The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain on an eleven-point numerical scale.
The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
|
Within 48 hours post CS
|
Numerical rating scale (0-10) with movement
Time Frame: Within 48 hours post CS
|
The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain on an eleven-point numerical scale.
The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
|
Within 48 hours post CS
|
Ramsay scale
Time Frame: within 24 hours post CS
|
Ramsay scale measures level of sedation: 1 Patient is anxious and agitated or restless, or both. 2 Patient is co-operative, oriented, and tranquil.
3 Patient responds to commands only.
4 Patient exhibits brisk response to light glabellar tap or loud auditory stimulus.
|
within 24 hours post CS
|
Itching
Time Frame: within 24 hours post CS
|
Itching will be assessed as following: 0, none; 1, mild; 2, moderate; and 3, severe
|
within 24 hours post CS
|
Nausea
Time Frame: within 24 hours post CS
|
Nausea will be assessed as following: 0, none; 1, mild; 2, moderate; and 3, severe or vomiting
|
within 24 hours post CS
|
Surgery-to-first-ambulation time
Time Frame: within 48 hours post CS
|
Time from surgery to first ambulation of the patient
|
within 48 hours post CS
|
Surgery-to-breast-feeding time
Time Frame: within 48 hours post CS
|
Time from surgery to first breast-feeding
|
within 48 hours post CS
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 0120-251/2019/4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
Tanta UniversityRecruiting
-
Damanhour Teaching HospitalRecruiting
-
SSM Health Bone and Joint Hospital at St AnthonyRecruitingAnalgesiaUnited States
-
Mansoura UniversityRecruiting
-
Makassed General HospitalRecruiting
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Ataturk UniversityCompleted
-
Abd-Elazeem Abd-Elhameed ElbakryActive, not recruiting
Clinical Trials on Quadratus Lumborum Block type 2
-
Federal University of São PauloIrmandade da Santa Casa de Misericordia de Sao PauloUnknown
-
Sohag UniversityCompletedEpidural Analgesia | Cesarean Section | Painless LaborEgypt
-
The General Authority for Teaching Hospitals and...CompletedCesarean Section | Quadratus Lumborum Block | Transversus Abdominis Plane BlockEgypt
-
Mansoura UniversityCompleted
-
Assuta Medical CenterUnknownSpinal Stenosis Lumbar | Spondylolisthesis | Degeneration Spine | Fusion of Spine, Lumbar RegionIsrael
-
CHU de ReimsUnknownTotal Hip Replacement SurgeryFrance
-
South Valley UniversityRecruiting
-
Alexandria UniversityCompletedTransmuscular Quadratus Lumborum Block Hip SurgeryEgypt
-
Ondokuz Mayıs UniversityCompletedComparison of the Effects of QLB 2 and QLB 3 on Post-operative Analgesia in Cesarean Section SurgeryChronic Pain | Analgesia | Acute PainTurkey
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedPostoperative Pain | Cesarean Section Complications | Patient Satisfaction | BlockTurkey